Gentamicin
- Product NDC
- 63323-173
- 11-digit product format
- 633230173
- Labeler code
- 63323
- Product ID
- 63323-173_9f48c9f7-08fd-4652-911c-c2c221a34ed3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GENTAMICIN
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA062366
- Marketing category
- ANDA
- Marketing start
- 2004-11-29
- Substance
- GENTAMICIN SULFATE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A062366-001 | GENTAMICIN SULFATE | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 |
| A062366-002 | GENTAMICIN SULFATE | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A062366-001 | AP |
| A062366-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A062366-001 | GENTAMICIN SULFATE | EQ 40MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1983-08-04 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A062366-002 | GENTAMICIN SULFATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 1986-02-06 | 4b0b4de00fa7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A062366-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A062366-002 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A062366-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A062366-002 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A062366-001 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A062366-002 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062366-001 | AP | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062366-002 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A062366-001 | AP | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A062366-002 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A062366-001 | AP | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A062366-002 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A062366-001 | AP | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A062366-002 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A062366-001 | AP | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A062366-002 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A062366-001 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A062366-002 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A062366-001 | AP | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A062366-002 | AP | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062366-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062366-002 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A062366-001 | AP | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A062366-002 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A062366-001 | AP | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A062366-002 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A062366-001 | AP | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A062366-002 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A062366-001 | AP | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A062366-002 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A062366-001 | AP | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A062366-002 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A062366-001 | AP | 1 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A062366-002 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A062366-001 | AP | 1 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | A062366-002 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A062366-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A062366-002 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A062366-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A062366-002 | AP | 1 | 3a93d1ddd44b… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Gentamicin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GENTAMICIN SULFATE | 10 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 8X7386QRLV | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1870676 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 63413469-c676-48a3-a945-7d2489b535ef | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3b7b3a7a-635f-32a3-0c6c-7ad028e3de91 | Product name | 2 | 20250107 |
| 43025f0d-698c-68da-cec9-ea4261a7ef7a | Product name | 2 | 20250107 |
| d3946667-8212-d1f2-67e1-5643a329bb56 | Product name | 2 | 20200403 |
| 4ce5dce5-e8a7-e4f6-0059-b527e4307477 | Product name | 2 | 20190501 |
| 48b05f5d-d2fc-45ab-76e8-3cb5bd44890d | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-173-01 | Gentamicin | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 8 | |
| 63323-173-02 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 8 | |
| 63323-173-41 | Gentamicin | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 4 | |
| 63323-173-94 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 4 | |
| 63323-173-95 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 3 | |
| 63323-173-95 | Gentamicin | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-173-01 | ML - Milliliter | 63323-173 | ced61a19-c526-4301-9865-ba40e8c21820 | 1 | 2022-08-04 |
| 63323-173-02 | ML - Milliliter | 63323-173 | 5fd11ec3-8c33-4c79-b4c7-bec645fb2873 | 1 | 2012-07-24 |
| 63323-173-41 | ML - Milliliter | 63323-173 | d5f59524-b9ee-4918-b264-40afffbbcc2e | 1 | 2023-01-09 |
| 63323-173-94 | ML - Milliliter | 63323-173 | 53fc2922-96f5-4ce1-8684-be9e028a9a6e | 1 | 2013-12-02 |
| 63323-173-95 | ML - Milliliter | 63323-173 | f3a52ac6-ae2b-4af9-8def-100e9d3032b7 | 1 | 2014-02-04 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-173 | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 8 | Current NDC, Legacy NDC, 2 package rows | 20231215_be5b414e-d598-4721-80ee-5836156ad210.zip |
| 63323-173 | GENTAMICIN (GENTAMICIN) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 4 | Current NDC, Legacy NDC, 2 package rows | 20240106_8bdeef7f-ad8e-46e0-a872-e945eae51d68.zip |
| 63323-173 | GENTAMICIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | Current NDC, Legacy NDC, 2 package rows | 20241017_63413469-c676-48a3-a945-7d2489b535ef.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentamicin | GENTAMICIN SULFATE | Henry Schein, Inc | 84f6eb1c-a287-489a-8c3e-aa5954cf1992 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | 062366 ANDA062366 |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | 63413469-c676-48a3-a945-7d2489b535ef | 2024-10-14 | Boxed warning, Warnings, Adverse reactions | 062366 ANDA062366 63323-173 |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | 84f5c763-1cd3-4d85-9afb-934db8666fbf | 2024-10-11 | Boxed warning, Warnings, Adverse reactions | 062366 ANDA062366 |
| GENTAMICIN | GENTAMICIN | HF Acquisition Co LLC, DBA HealthFirst | c1ff0cdc-ac5d-30ca-e053-2a95a90a5066 | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 062366 ANDA062366 |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | 8bdeef7f-ad8e-46e0-a872-e945eae51d68 | 2023-12-20 | Boxed warning, Warnings, Adverse reactions | 062366 ANDA062366 63323-173 |
| Gentamicin | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 09cf88af-59da-f147-e063-6294a90aac99 | 2023-11-10 | Boxed warning, Warnings, Adverse reactions | 062366 ANDA062366 |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | 0cce2238-28d3-4280-b520-ffc3067a2ffa | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | 062366 ANDA062366 |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | be5b414e-d598-4721-80ee-5836156ad210 | 2023-10-24 | Boxed warning, Warnings, Adverse reactions | 062366 ANDA062366 63323-173 |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | a73a5453-c091-43fd-aae2-d992152363b1 | 2023-10-20 | Boxed warning, Warnings, Adverse reactions | 062366 ANDA062366 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1870676 | gentamicin sulfate 20 MG in 2 ML Injection | PSN | be5b414e-d598-4721-80ee-5836156ad210 | 8 |
| 1870676 | 2 ML gentamicin 10 MG/ML Injection | SCD | be5b414e-d598-4721-80ee-5836156ad210 | 8 |
| 1870676 | gentamicin (as gentamicin sulfate) 20 MG per 2 ML Injection | SY | be5b414e-d598-4721-80ee-5836156ad210 | 8 |
| 1870676 | gentamicin sulfate 20 MG in 2 ML Injection | PSN | 8bdeef7f-ad8e-46e0-a872-e945eae51d68 | 4 |
| 1870676 | 2 ML gentamicin 10 MG/ML Injection | SCD | 8bdeef7f-ad8e-46e0-a872-e945eae51d68 | 4 |
| 1870676 | gentamicin (as gentamicin sulfate) 20 MG per 2 ML Injection | SY | 8bdeef7f-ad8e-46e0-a872-e945eae51d68 | 4 |
| 1870676 | gentamicin sulfate 20 MG in 2 ML Injection | PSN | 63413469-c676-48a3-a945-7d2489b535ef | 3 |
| 1870676 | 2 ML gentamicin 10 MG/ML Injection | SCD | 63413469-c676-48a3-a945-7d2489b535ef | 3 |
| 1870676 | gentamicin (as gentamicin sulfate) 20 MG per 2 ML Injection | SY | 63413469-c676-48a3-a945-7d2489b535ef | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63323-173-01 | 63323017301 | 2 mL in 1 VIAL | 2 ml | Historical | ||||
| 63323-173-02 | 63323017302 | 25 VIAL in 1 TRAY (63323-173-02) / 2 mL in 1 VIAL (63323-173-01) | 25 vial | 2004-11-29 | 0000-00-00 | No | No | Current |
| 63323-173-41 | 63323017341 | 2 mL in 1 VIAL | 2 ml | Historical | ||||
| 63323-173-94 | 63323017394 | 25 VIAL in 1 TRAY (63323-173-94) / 2 mL in 1 VIAL (63323-173-41) | 25 vial | 2004-11-29 | 0000-00-00 | No | No | Current |
| 63323-173-95 | 63323017395 | 25 VIAL in 1 TRAY (63323-173-95) / 2 mL in 1 VIAL | 25 vial | 2004-11-29 | 0000-00-00 | No | No | Current |